1. DR MOHAMMED ARIF. ASSOCIATE PROFESSOR. CONSULTANT VIROLOGIST. HEAD OF THE VIROLOGY UNIT. Viral infection of the respiratory tract -- 2

2. 1- Influenza ( Flu ).  Viral etiology المسبب : Influenza viruses.  Family: Orthomyxoviridae.  Pleomorphic, enveloped with helical nucleocapsid.  Two glycoprotein spikes هذه الاشواك هي التي تنشأ ضدها المناعه, the hemagglutinine( HA ) and the neuraminidase (N A).  The viral genome consists of 7 - 8 segments مهمه جدا – مجزاه - of ss-RNA ( negative polarity ).

3. Glycoprotein spikes. قراءه بتركيز فقط  Hemagglutinine spike:  Attachment of the virus to the cell surface receptors.  The main neutralizing antigen.  Antibodies to the HA is responsible for immunity.  16 hemagglutinine antigenic type, H1 – H16

4. Glycoprotein spikes.  Neuraminidase (N ).  Responsible for release of the progeny virus particles from the infected cell.  Nine antigenic type, N1 – N9.

5. Influenza virus.

7. Influenza viruses.  Influenza viruses: There are three types of influenza viruses, known as A, B, and C. مهمه – الصفات العامه لكل منها مهمه  Influenza A viruses:  Divided into subtypes based on the hemagglutinine and neuraminidase proteins.  The currently circulating subtypes are:H1N1 & H3N2.

8. Influenza  Influenza A viruses infect humans as well as wild birds, pigs, horses, whales and seals. النوع الوحيد الذي يصيب الحيوانات  They exhibit major ( antigenic shift تغير كبير في الجينات – لا يحدث الا في هذا النوع - ) and minor (antigenic تغير – طفره – صغيره بالجينات drift) antigenic variations.  They cause epidemic and pandemic. مسبب لوباءات عالميه

9. Influenza A viruses, Genetic recombination.

10. Influenza  Influenza B virus:  There is no subtypes.  They infect only humans.  They exhibit minor antigenic variations (drift ).  They cause epidemic but not pandemic.

11. Influenza  Influenza C virus:  There is no subtypes.  They infect only humans.  Antigenically stable.  Cause mild diseases.

12. Antigenic variations in influenza viruses  1- Antigenic shift:  Occurs only in influenza A viruses.  A complete change in the hemagglitinin alone or the hemagglutinin and neuraminidase.  This change is due to genetic recombination( genetic assortment) between human and animal strains, both are influenza A viruses.  The RNA segments that codes for the hemagglutinin is transferred from the animal strain to the human

13. Antigenic shift resulting in a new subtype of human influenza type A ( the hemagglutinin came from animal influenza A strain).  Antigenic shift produces a new influenza A subtype.

14. Antigenic shift.

15. Antigenic drift  Occurs in both influenza A and B viruses.  It is a minor antigenic change in the hemagglutinin due to mutation in the hemagglutinin gene.  Antigenic drift produces a new virus strain, that may not be recognized by the immune system.  Reinfection occurs.

16. Influenza A pandemics'. قراءه فقط  Pandemic is a worldwide epidemic of a disease.  During the last 100-years, there have been four influenza A pandemics.  1- 1918 – 1919,Spanish flu, H1N1.  Caused 500,000 deaths in the USA.  Caused 20 – 50 millions deaths worldwide.  2- 1957 – 1958, Asian flu, H2N2.  Complete change (shift) occurs in both HA and NA.  Approximately 70,000 deaths in the USA.

17. Influenza A pandemics.  3- 1968 – 1969, Hong Kong flu, H3N2.  Complete change occurs only in the HA.  In 1976, swine flu, H1N1 reappeared.  Affected individuals less than 20 years of age.  The virus did not cause pandemic.  4- 2009, pandamic swine flu ( H1N1 )  Infected both adults and children.

18. Influenza  Pathogenesis : the virus infects the epithelial cells of the nose, throat, bronchi and occasionally the lungs.  Transmission: By inhalation of respiratory droplets.

19. Symptoms.  Incubation period : 1 – 4 days. غير مهمه  Symptoms : fever, malaise, chills, sore throat, hoarseness, headache, cough and generalized aches.  Prognosis : Recovery is usual. Symptoms last for about 5 days, but weakness often persists longer.

20. Influenza  Complications:  Primary influenza pneumonia.  Secondary bacterial pneumonia.

21. Influenza vaccine  Two types of vaccines:  1-The flu shot vaccine:  Inactivated ( killed vaccine ).  Given to people older than 6-months, including healthy people and those with chronic medical conditions. 2- The nasal spray flue vaccine ( Flu mist ):  This is a live attenuated vaccine.  Approved for use in healthy people between 5- 49 years of age.

22. Notes on the flue vaccine  Both vaccine contain the current influenza viruses( H1N1, H3N2 and the current influenza B strain).  Vaccine should be given in October or November, before the influenza season begins.  The flu shot vaccine is recommended to healthy people as well as high risk groups ( elderly, patients with chronic pulmonary or cardiac diseases).  The flu shot vaccine is inactivated vaccine.

23. Lab diagnosis 1- In adult, lab diagnosis is not usually needed. Diagnosis depends mainly on the symptoms. But, if the lab diagnosis is needed, Isolation of the virus in tissue culture followed by identification of the isolated virus. Specimens : throat swab. 2- In infants and young children, direct demonstration of the virus in the infected cells of the nasopharyngeal aspirate.

24. Nasopharyngeal aspirate

25. Treatment اعرف اسم الدواء والقروب اللي يؤثر عليه ولا تحفظ الدوز  Four anti-viral drugs are approved for treatment of influenza. 1- Amantadine and remantadine:  Active only against influenza A.  Inhibit virus replication.  The prophylactic dose is 200 mg/day for the duration of influenza A outbreak.

26. Treatment 2- Zanamivir (Relenza):  Active against influenza A and B.  Neuraminidase inhibitor.  Administered by inhalation.  Dose: two buffs twice daily, for people older than 7- years.

27. Treatment 3- Oseltamivir ( Tamiflu ) علاج الانفلونزا العاديه وانفلونزا الخنازير :  Active against influenza A and B.  Neuraminidase inhibitor.  Administered orally.  Adult dose: 75 mg twice a day for five days.  For prophylactic use, the dose is 75 mg once a day for at least 7-days.

28. Avian flu انفلونزا الطيور Viral etiology : Avian influenza type A virus. Family : Typical orthomyxovirus. Epidemiology : Wild birds are the natural reservoir for the virus. They shed the virus in saliva, nasal secretion and feces.  All domestic poultry are susceptible to infection.  They become infected, when they eat food contaminated with secretion or excretion from infected bird.  Avian influenza viruses do not usually infect human.  The high risk group are those who working in poultry farms and those who are in close contact with poultry.

29. Avian flu Symptoms in human :  Ranges from typical flu to severe acute respiratory disease.  Diarrhea, abdominal pain and bleeding from the nose have been reported. Treatment :  Should be initiated within 48hours.  Oseltamivir and zanamivir are used. Lab diagnosis : PCR, detection of the viral RNA in throat swap and sputum.

30. Severe Acute Respiratory Distress ( SARS ) Viral etiology : SARS associated corona virus. Family : Coronaviridae. Structure : enveloped, helical nucleocapsid. The viral genome is ss- RNA with positive polarity. Transmission : By inhalation of respiratory droplets and direct contact with respiratory secretions. Incubation period : 2-7 days. Symptoms : fever> 38c, chills, malaise, headache, cough, dyspnea and pneumonia. Lab diagnosis : by detection of the viral RNA in throat swap. Treatment : Supportive. There is no vaccine.